Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
1998-7-23
|
pubmed:abstractText |
Interleukin 6 (IL-6) serves as a growth factor for mouse plasmacytomas. As a model for IL-6-mediated growth of plasmacytomas, we study IL-6-dependent B-cell hybridomas, which can be generated through fusion of B lymphocytes with a plasmacytoma cell line, e.g., SP2/0. In the present report, we have investigated the peculiar behavior of B-cell hybridomas with respect to IL-6 dependence. We demonstrate that although newly generated hybridomas are IL-6 dependent, many hybridomas lose this dependency at frequencies as high as 50%, shortly after fusion. We speculated that the loss of IL-6-dependent growth is due to the well-known chromosomal instability of B-cell hybridomas. Consequently, loss of IL-6 dependence is the result of loss of a specific chromosome(s). This model implies the existence of an "IL-6 dependency" gene, the loss of which makes hybridomas capable of proliferating in the absence of IL-6. Because SP2/0 is IL-6 independent, the IL-6-dependent phenotype of B-cell hybridomas, and hence the IL-6 dependency gene, must be derived from the B lymphocyte. We have tested this model by generating human/mouse B-cell hybridomas through fusion of human B lymphocytes with SP2/0. We then analyzed the human chromosome content of 10 IL-6-dependent and 14 IL-6-independent subclones. From that analysis we concluded that the presence of human chromosome 21 correlated with IL-6 dependence. This correlation was confirmed by microcell fusion experiments in which a single copy of chromosome 21 was introduced into IL-6-independent hybridomas, resulting in reconstitution of the IL-6-dependent phenotype. We therefore conclude that chromosome 21 carries an IL-6 dependency gene.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2863-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9661903-Animals,
pubmed-meshheading:9661903-B-Lymphocytes,
pubmed-meshheading:9661903-Cell Division,
pubmed-meshheading:9661903-Chromosomes, Human, Pair 21,
pubmed-meshheading:9661903-Female,
pubmed-meshheading:9661903-Humans,
pubmed-meshheading:9661903-Hybridomas,
pubmed-meshheading:9661903-Interleukin-6,
pubmed-meshheading:9661903-Karyotyping,
pubmed-meshheading:9661903-Mice,
pubmed-meshheading:9661903-Phenotype
|
pubmed:year |
1998
|
pubmed:articleTitle |
Human chromosome 21 determines growth factor dependence in human/mouse B-cell hybridomas.
|
pubmed:affiliation |
Department of Autoimmune Diseases, Central Laboratory of The Netherlands Red Cross Transfusion Service, Academic Medical Center, University of Amsterdam. s.ebeling@lab.azu.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|